oxaprozin

网络  奥沙普秦; 奥沙普嗪; 噁丙嗪; 恶丙嗪; 诺松

医学



双语例句

  1. To establish fluorescent method for the determination of oxaprozin enteric-coated capsules.
    目的:建立奥沙普嗪肠溶胶囊的荧光测定法。
  2. Objective To establish a HPLC method for determining the concentration of oxaprozin in human plasma.
    目的建立奥沙普嗪血药浓度的高效液相色谱法(HPLC法)。
  3. Three aspects of Oxaprozin are discussed in this article, Which inclnde the optimum design of reaction conditions, purification of the find product and preparation of the Calcium Salt.
    本文讨论了(口恶)丙嗪合成条件的优化设计,产品的纯制方法及钙盐的制备方法。
  4. Objective: To study the influence of oxaprozin on platelet aggregation and thrombosis in rabbits and rats.
    目的:研究奥沙普嗪对家兔和大鼠血小板聚集和血栓形成的影响。
  5. Objection: To determinate oxaprozin by colorimetric method.
    目的:用比色法测定奥沙普嗪的含量。
  6. OBJECTIVE: To prepare oxaprozin dispersible tablets, and the dissolution rate of it was compared with the other two commericial tablets.
    目的:制备卟恶丙嗪分散片,并将其与另两种市售片剂的溶出度进行比较。
  7. Objective: To determinate oxaprozin and its tablet.
    前言:目的:测定奥沙普秦及其片剂的含量。
  8. Aim An HPLC method was established for the study on pharmacokinetics and bioequivalence of oxaprozin enteric tablet in healthy volunteers.
    目的建立一种HPLC检测法,以测定人体血浆中奥沙普秦的药物浓度,并对两种奥沙普秦肠溶片生物等效性进行评价。
  9. Objective: To determine the content of oxaprozin.
    目的:测定奥沙普秦含量。
  10. OBJECTIVE To establish a method of nonaqueous capillary electrophoresis ( NACE) to separate non-steroidal anti-inflammatory drugs ( NSAIDs) and determine the content of oxaprozin in enteric-coated tablet.
    目的建立一种非水毛细管电泳法(NACE)分离非甾体抗炎药物,并对奥沙普秦肠溶片进行定量分析。
  11. Study on pharmacodynamics and permeation of oxaprozin gel in vitro
    奥沙普秦凝胶剂的体外渗透性及药效学
  12. Study on assay method of oxaprozin in its liniment was reported.
    本文报道呕恶丙嗪擦剂含量测定方法学的研究。
  13. METHODS: The permeation and release of oxaprozin gel was measured by using Franz diffusion cell.
    方法:采用Franz扩散池,进行奥沙普秦凝胶剂体外渗透性和释放度实验。
  14. Determination of Oxaprozin and its Tablets by HPLC
    奥沙普秦及其片剂的HPLC测定
  15. Preparation and determination of Oxaprozin gel
    恶丙嗪凝胶剂的制备及含量测定
  16. RESULTS: The ex vivo permeability of oxaprozin gel was the best when the carbomer 940 used as its base material with its ex vivo permeability coefficient at 22.77 μ g/ ( cm2 · h).
    结果:以卡波姆940为基质的奥沙普秦凝胶体外渗透系数为22.77/μg/(cm2·h),其体外渗透性最佳。
  17. Conclusion: The method is used to determine the content of oxaprozin tablet and raw material medicine, which is simple, rapid, qualitative, accurate with satisfactory results.
    结论:该法快速准确、操作方便,用于样品及原料药中的奥沙普秦的含量测定,结果令人满意。
  18. Phase III trials of oxaprozin enteric coated tablet in treatment of rheumatoid arthritis
    奥沙普秦肠溶片治疗类风湿关节炎的III期临床试验
  19. Study on Stability and Prescription Screening of Oxaprozin Gel
    奥沙普秦凝胶剂处方筛选及稳定性研究
  20. Studies on Solubility of Oxaprozin
    恶丙嗪溶解性能的研究
  21. The bioequivalence of oxaprozin enteric tablet in healthy volunteers measured with HPLC
    奥沙普秦肠溶片HPLC测定法及其人体生物等效性研究
  22. CONCLUSIONS The results showed that the percutaneous absorption of Oxaprozin was a zero-order releasing kinetics through nonpolar channel, and 10% oleic acid plus 1% azone was the most effective one.
    结论:奥沙普秦透皮吸收符合非极性通道释放的零级动力学方程,其中以10%油酸加1%月桂氮芯卓酮组成的混合促进剂作用最显著。
  23. Determination of Oxaprozin Gel by HPLC
    奥沙普秦凝胶剂的HPLC测定
  24. OBJECTIVE To prepare the complex between oxaprozin and hydrogenated phospholipid.
    目的制备奥沙普秦氢化磷脂复合物。
  25. Objective: To prepare oxaprozin liposome.
    目的:制备恶丙嗪脂质体。
  26. OBJECTIVE: To compare the relative bioavailability of 2 kinds of domestic oxaprozin enteric tablets.
    目的:比较2种国产奥沙普秦肠溶片的相对生物利用度。
  27. RESULTS The oxaprozin-PEG 6000 solid dispersion was a simple-lower-eutectic compound. The oxaprozin was dispersed in PEG 6000 as micro-crystallite form.
    结果:卟恶丙嗪PEG6000固体分散体是一种简单低共熔混合物,卟恶丙嗪以超细结晶状态分散在PEG载体中。
  28. Objective To synthesize nonsteroidal anti-inflammatory drug oxaprozin.
    目的合成非甾体类抗炎药奥沙普秦。

英英释义

noun

  1. a nonsteroidal anti-inflammatory drug (trade name Daypro)

      Synonym:    Daypro